WebApr 4, 2024 · SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2024 2024 2024 2024 2024 2024 2024 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 … WebFeb 23, 2011 · Incyte Corp (INCY) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010. Home. SEC Filings. Incyte Corp (INCY) 10-K Annual Report Wed Feb 23 2011; ... Incyte Corporation (Nasdaq:INCY) today reported fourth quarter and full year 2010 financial results, provided 2011 key objectives, and announced its 2011 financial ...
Incyte and Merck Expand Clinical Collaboration to Include Phase 3 …
WebJan 27, 2024 · According to the SEC, within minutes of learning that information, Panuwat purchased 578 call options for shares of Incyte, another mid-cap biopharmaceutical … WebFeb 8, 2024 · Incyte Reports 2024 Fourth Quarter and Year-end Financial Results, and Provides 2024 Financial Guidance and Updates on Key Clinical Programs Total product … fishing weigh scales
Cyber security training, awareness and exercises INCYTE
WebIncyte prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Incyte investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information ... WebMar 3, 2024 · MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) and Incyte Corporation (NASDAQ: INCY) announced today that their joint collaboration and license agreement for the further development and global commercialization of MorphoSys' investigational compound tafasitamab (MOR208) has … WebFeb 8, 2024 · The SEC alleges that Panuwat knew, or was reckless in not knowing, that the information about Medivation’s imminent acquisition at a significant premium was … fishing weight pegs